Valuation (40%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 6.97 | 13.34 |
PEG Ratio (TTM) | -0.64 | -9.52 |
P/S Ratio (TTM) | 0.61 | 2.14 |
P/B Ratio (TTM) | 1.87 | 21.34 |
P/FCF Ratio (TTM) | 180.03 | 24.62 |
Price to 5YR AVG Earnings Ratio | N/A | 27.04 |
Price to 5YR AVG FCF Ratio | N/A | 43.68 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.59% | 12.22% |
ROE (TTM) | 25.59% | 44.17% |
Net Profit Margin (TTM) | 8.74% | 13.71% |
ROIC 5YR AVG | N/A | 14.41% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -8.81% | 112.20% | N/A |
Revenue | -2.64% | -3.86% | N/A |
Net Income | -9.49% | 110.86% | N/A |
Cash Flow | 200.83% | 30.09% | N/A |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.68 | 1.64 |
Quick Ratio (TTM) | 5.47 | 1.15 |
D/E Ratio (TTM) | 3.60 | 2.34 |
Interest Coverage (TTM) | 2.96 | 12.14 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 2.14 | 3.94 |
LTL to 5YR AVG FCF | N/A | 11.98 |
Shares Outstanding Growth 5YR AVG | N/A | -1.86% |